Bioventus Inc. (BVS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Bioventus Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 21.81x | -20.46x | -2.11x | -1.01x | 34.01x | 44.13x |
| P/B Ratio | 2.69x | 4.64x | 1.90x | 0.49x | 1.44x | 5.09x |
| P/S Ratio | 0.87x | 1.20x | 0.64x | 0.31x | 1.53x | 2.25x |
| Profitability | ||||||
| Gross Margin | 67.3% | 67.7% | 64.1% | 64.6% | 70.3% | 72.7% |
| Operating Margin | 10.3% | -2.1% | -16.0% | -32.7% | 2.8% | 6.6% |
| Net Margin | 4.0% | -5.9% | -30.5% | -31.0% | 4.5% | 5.1% |
| EBITDA Margin | 18.6% | 6.8% | -4.5% | -23.7% | 10.6% | 16.9% |
| Liquidity | ||||||
| Current Ratio | 1.70x | 1.31x | 1.53x | 0.90x | 1.45x | 1.73x |
| Quick Ratio | 1.19x | 0.87x | 1.01x | 0.62x | 1.11x | 1.49x |
| Leverage | ||||||
| Debt/Equity | 1.69x | 2.27x | 2.27x | 1.29x | 0.78x | 1.32x |
YoY = year-over-year change. Source: FMP..